About the Anna - Maria Kellen Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's
partnerships with nonprofit organizations, pharmaceutical and
biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians
with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innovation.